FI933472A0 - Peptider med foermaoga att inhibera effekten av hiv-proteas, deras framstaellning och terapeutiska anvaendning - Google Patents
Peptider med foermaoga att inhibera effekten av hiv-proteas, deras framstaellning och terapeutiska anvaendningInfo
- Publication number
- FI933472A0 FI933472A0 FI933472A FI933472A FI933472A0 FI 933472 A0 FI933472 A0 FI 933472A0 FI 933472 A FI933472 A FI 933472A FI 933472 A FI933472 A FI 933472A FI 933472 A0 FI933472 A0 FI 933472A0
- Authority
- FI
- Finland
- Prior art keywords
- therapeutiska
- inhibera
- foermaoga
- peptider
- effekten
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21174692 | 1992-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI933472A0 true FI933472A0 (fi) | 1993-08-05 |
FI933472A FI933472A (fi) | 1994-02-08 |
Family
ID=16610902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI933472A FI933472A (fi) | 1992-08-07 | 1993-08-05 | Peptider med foermaoga att inhibera effekten av HIV-proteas, deras framstaellning och terapeutiska anvaendning |
Country Status (16)
Country | Link |
---|---|
US (1) | US5629406A (fi) |
EP (1) | EP0587311A1 (fi) |
KR (1) | KR0177838B1 (fi) |
CN (1) | CN1091432A (fi) |
AU (1) | AU662434B2 (fi) |
CA (1) | CA2103536A1 (fi) |
CZ (1) | CZ161993A3 (fi) |
FI (1) | FI933472A (fi) |
HU (1) | HUT64774A (fi) |
IL (1) | IL106600A (fi) |
MX (1) | MX9304837A (fi) |
NO (1) | NO932813L (fi) |
NZ (1) | NZ248332A (fi) |
PH (1) | PH31249A (fi) |
RU (1) | RU2106357C1 (fi) |
ZA (1) | ZA935697B (fi) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6313094B1 (en) | 1990-12-11 | 2001-11-06 | Japan Energy Corporation | β-amino-α-hydroxycarboxylic acid derivatives and HIV protease inhibitors |
DE69524527D1 (de) * | 1994-10-14 | 2002-01-24 | Japan Energy Corp | AIDS-hemmende Arzneizubereitung und Verfahren |
DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
US6008228A (en) * | 1995-06-06 | 1999-12-28 | Hoffman-La Roche Inc. | Pharmaceutical compositions containing proteinase inhibitors |
US6222043B1 (en) | 1995-06-30 | 2001-04-24 | Japan Energy Corporation | Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof |
CA2179935C (en) * | 1995-06-30 | 2010-09-07 | Ryohei Kato | Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
US6291432B1 (en) | 1996-12-27 | 2001-09-18 | Japan Energy Corporation | Tripeptide compounds and anti-AIDS medicine |
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
ZA982068B (en) | 1997-03-14 | 1998-09-16 | Snow Brand Milk Products Co Ltd | Agent for preventing and/or treating cachexia |
WO1998051295A1 (fr) * | 1997-05-14 | 1998-11-19 | Nissui Pharmaceutical Co., Ltd. | Inhibiteur de la protease du vih-1, leur procede de production, et compositions medicinales |
ES2147162B1 (es) | 1999-01-27 | 2001-03-16 | Lacer Sa | "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias". |
SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
CO5300399A1 (es) | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen |
AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
US7005439B2 (en) | 2000-06-20 | 2006-02-28 | Astrazeneca Ab | Compounds |
GB0104050D0 (en) | 2001-02-19 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
AR035230A1 (es) | 2001-03-19 | 2004-05-05 | Astrazeneca Ab | Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos |
GB0107228D0 (en) | 2001-03-22 | 2001-05-16 | Astrazeneca Ab | Chemical compounds |
SE0101038D0 (sv) | 2001-03-23 | 2001-03-23 | Astrazeneca Ab | Novel compounds |
WO2002081454A1 (en) * | 2001-04-09 | 2002-10-17 | Dr. Reddy's Laboratories Ltd. | Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them |
CN100350036C (zh) | 2001-04-27 | 2007-11-21 | 宝洁公司 | 用于控制生物膜的装置和方法 |
HN2002000136A (es) * | 2001-06-11 | 2003-07-31 | Basf Ag | Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis |
US7094909B2 (en) * | 2001-06-11 | 2006-08-22 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
US7169932B2 (en) * | 2001-06-11 | 2007-01-30 | Pfizer Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
SE0103818D0 (sv) | 2001-11-15 | 2001-11-15 | Astrazeneca Ab | Chemical compounds |
WO2003051841A2 (en) | 2001-12-14 | 2003-06-26 | Novo Nordisk A/S | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
SE0301369D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
KR20060097047A (ko) * | 2003-12-04 | 2006-09-13 | 화이자 인코포레이티드 | 프로테아제 억제제로서 유용한 화합물의 제조 방법 |
WO2005054214A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Inc. | Methods of preparing compounds useful as protease inhibitors |
WO2005121094A1 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
TW200738634A (en) | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
FR2904317A1 (fr) | 2006-07-27 | 2008-02-01 | Inst Nat Sante Rech Med | Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques |
EP2085390A1 (en) | 2008-01-31 | 2009-08-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2056911C (en) * | 1990-12-11 | 1998-09-22 | Yuuichi Nagano | Hiv protease inhibitors |
CA2060844A1 (en) * | 1991-02-08 | 1992-08-09 | Yabe Yuichiro | Beta-amino-alpha-hydroxycarboxylic acids and their use |
-
1993
- 1993-08-05 FI FI933472A patent/FI933472A/fi unknown
- 1993-08-05 NZ NZ248332A patent/NZ248332A/xx unknown
- 1993-08-05 AU AU44438/93A patent/AU662434B2/en not_active Ceased
- 1993-08-05 ZA ZA935697A patent/ZA935697B/xx unknown
- 1993-08-05 IL IL106600A patent/IL106600A/xx not_active IP Right Cessation
- 1993-08-06 PH PH46649A patent/PH31249A/en unknown
- 1993-08-06 RU RU93050122A patent/RU2106357C1/ru active
- 1993-08-06 CZ CZ931619A patent/CZ161993A3/cs unknown
- 1993-08-06 HU HU9302286A patent/HUT64774A/hu unknown
- 1993-08-06 EP EP93306258A patent/EP0587311A1/en not_active Withdrawn
- 1993-08-06 CA CA002103536A patent/CA2103536A1/en not_active Abandoned
- 1993-08-06 NO NO932813A patent/NO932813L/no unknown
- 1993-08-06 KR KR1019930015304A patent/KR0177838B1/ko not_active IP Right Cessation
- 1993-08-07 CN CN93117625A patent/CN1091432A/zh active Pending
- 1993-08-09 MX MX9304837A patent/MX9304837A/es unknown
-
1994
- 1994-04-14 US US08/227,588 patent/US5629406A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ248332A (en) | 1995-01-27 |
AU662434B2 (en) | 1995-08-31 |
KR940003965A (ko) | 1994-03-14 |
US5629406A (en) | 1997-05-13 |
MX9304837A (es) | 1994-05-31 |
IL106600A (en) | 1997-09-30 |
NO932813L (no) | 1994-02-08 |
RU2106357C1 (ru) | 1998-03-10 |
CZ161993A3 (en) | 1994-02-16 |
PH31249A (en) | 1998-06-18 |
NO932813D0 (no) | 1993-08-06 |
CN1091432A (zh) | 1994-08-31 |
HU9302286D0 (en) | 1993-10-28 |
FI933472A (fi) | 1994-02-08 |
ZA935697B (en) | 1994-03-10 |
KR0177838B1 (ko) | 1999-04-01 |
EP0587311A1 (en) | 1994-03-16 |
HUT64774A (en) | 1994-02-28 |
AU4443893A (en) | 1994-02-10 |
IL106600A0 (en) | 1993-12-08 |
CA2103536A1 (en) | 1994-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI933472A0 (fi) | Peptider med foermaoga att inhibera effekten av hiv-proteas, deras framstaellning och terapeutiska anvaendning | |
FI930620A (fi) | Bensimidazolylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
FI922721A (fi) | Ammunitionskomponent med laog skadeegenskaper, med en tvaokomponentig explosionsladdning och foerfarande foer uppnaoende av en fragmentationseffekt | |
FI932625A0 (fi) | Anordning och foerfarande foer detektering av ytfel i laonga, i roerelse befintliga metallprodukter | |
FI931291A0 (fi) | Indol- och indazolderivat foer behandling och foerebyggande av hjaernsjukdomar, deras framstaellning och anvaendning | |
FI935829A0 (fi) | Anlaeggning och foerfarande foer uttnyttjning av braennbara aemnen, speciellt industri- och hushaollsavfall | |
FI934221A0 (fi) | Piperidinderivat, framstaellning och terapeutisk anvaendning daerav | |
FI920589A0 (fi) | Foerfarande foer boejning och haerdning av glasskiva. | |
FI931682A (fi) | Tackykininreceptorantagonister, isokinoloner och deras framstaellning | |
FI922876A (fi) | Heterocykliska foereningar med reninhaemmande egenskaper, foerfarande foerframstaellning av dessa och anvaendning av dessa | |
FI905924A0 (fi) | Foerfarande och anordning foer att separera raomaterial med hjaelp av roentgenstraolning. | |
FI925974A0 (fi) | Humant rotavirus-hcr3, nyorganiserade stammar av detta och vaccinkompositioner innehaollande dessa | |
FI935132A0 (fi) | Fenolisk resolfanerharts, foerfarande och tillverkning | |
FI920665A0 (fi) | Foerfarande och arrangemang foer fastsaettning av slipsegment. | |
FI915704A0 (fi) | Foerfarande foer att foerbinda stycken med varandra och foerbindning enligt foerfarande. | |
FI923046A0 (fi) | Med skyddsoeverdrag foersedd kombination av faeltmadrass och baor. | |
FI932408A0 (fi) | Foerfarande foer foeraendring av deinkade returpappersmassors egenskaper, saerskilt fiberfraktion, och maskinsats foer genomfoerande av detta foerfarande | |
FI924974A0 (fi) | Foerfarande och anordning foer framstaellning av nytt, foer massaindustrius bruk avsett fibermaterial av vanligt stock- och fiberraomaterial | |
FI923648A (fi) | Foerfarande foer montering av en roermodul, en roermodul, och en vaermevaexlare foersedd med en saodan roermodul | |
FI922155A0 (fi) | Foerfarande och anordning foer att foerhindra stoeld av fordon. | |
FI922675A0 (fi) | Anordning foer filtrering av vaetska och saett att anvaenda filtret. | |
FI923137A0 (fi) | Anordning foer avkylning av foerbraenningsmotor med hjaelp av vaetska och omvandling av vaerme- energi till rotationsenergi. | |
FI716U1 (fi) | Anordning foer stoedande och fasthaollande av traestycken, foerdelaktigen under uppskaerning till braeder | |
FI922171A (fi) | Fordon foer lastning, kompaktering och avlaemning av avfall | |
FI914349A (fi) | Betonggjutform, foerfarande foer foerbindning av betonggjutformdelar tillvarandra och foerbindningsstycke |